Article
Clinical Neurology
Susana Otero-Romero, Luciana Midaglia, Pere Carbonell-Mirabent, Maria Zuluaga, Ingrid Galan, Jordi Rio, Georgina Arrambide, Marta Rodriguez-Barranco, Angela Vidal-Jordana, Joaquin Castillo, Breogan Rodriguez-Acevedo, Ana Zabalza, Carlos Nos, Manuel Comabella-Lopez, Patricia Mulero, Cristina Auger, Jaume Sastre-Garriga, Santiago Perez-Hoyos, Alex Rovira, Xavier Montalban, Mar Tintore
Summary: In this study, the effect of menopause on disability accumulation in women with clinically isolated syndrome (CIS) was evaluated. Results indicated that menopause did not increase the risk of disability in this population when considering Expanded Disability Status Scale (EDSS) trajectories along with age and disease duration. The annual increase in EDSS was higher in menopausal women compared to nonmenopausal women, but this difference disappeared when controlling for age and disease duration.
EUROPEAN JOURNAL OF NEUROLOGY
(2022)
Article
Endocrinology & Metabolism
Zegui Huang, Xianxuan Wang, Xiong Ding, Zefeng Cai, Weijian Li, Zekai Chen, Wei Fang, Zhiwei Cai, Yulong Lan, Guanzhi Chen, Weiqiang Wu, Zhichao Chen, Shouling Wu, Youren Chen
Summary: There is an association between new-onset metabolic syndrome at different ages and the risk of cardiovascular diseases. The risk is more intense in the group with metabolic syndrome onset at a younger age.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Steven C. Pike, Francesca Gilli, Andrew R. Pachner
Summary: Multiple sclerosis (MS) is a clinically heterogeneous disease and it is currently difficult to identify patients who may benefit from earlier interventions. Previous data showed that the CXCL13 index (I-CXCL13) can predict future disease activity in MS patients two years after diagnosis. This study confirms that the predictive ability of I-CXCL13 extends to CIS and RIS patients for at least five years, suggesting its potential use in guiding immunomodulatory therapy in MS.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Clinical Neurology
Lukas Haider, Ferran Prados, Karen Chung, Olivia Goodkin, Baris Kanber, Carole Sudre, Marios Yiannakas, Rebecca S. Samson, Stephanie Mangesius, Alan J. Thompson, Claudia A. M. Gandini Wheeler-Kingshott, Olga Ciccarelli, Declan T. Chard, Frederik Barkhof
Summary: The study found that after 30 years, the greatest differences in MRI measures between SPMS and RRMS were the higher number of cortical lesions in SPMS and the lower grey matter volume in SPMS. This suggests that cortical involvement, in terms of lesions and atrophy, is the main correlate of progressive disease and disability in individuals with very long follow-up, indicating it should be the target of therapeutic interventions.
Review
Medicine, General & Internal
Ismail Solmaz, Ibrahim Oncel
Summary: This study retrospectively evaluated pediatric CIS patients who developed POMS, finding that the presence of OCBs, family history of MS, and monosymptomatic onset may increase the risk of developing POMS. Most patients were started on interferons after the diagnosis of POMS.
TURKISH JOURNAL OF MEDICAL SCIENCES
(2022)
Article
Endocrinology & Metabolism
Zhi-Ju Li, Hao-Yue Hu, Zi-Ling Ding, Zi-Wei Bian, Ying-Hua Xu, Hui-Ting Wen, Ya-Li Qu, Jin-Dong Wang, Xiao-Li Huang, Dong Li, Jing Li, Gui-Fang Hu
Summary: This study found that women with cSLE have more aggressive disease activity during pregnancy compared to those with aSLE, with higher risks of active SLE and LN. However, after adjusting for pre-pregnancy characteristics and pregnancy factors, no significant association was found between cSLE and adverse pregnancy outcomes.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
(2022)
Article
Pediatrics
Kirana Veenin, Duangrurdee Wattanasirichaigoon, Bhoom Suktitipat, Saisuda Noojarern, Patcharee Lertrit, Thipwimol Tim-Aroon, Supannee Kaewsutthi, Suporn Treepongkaruna
Summary: This study did not find associations between mtDNA polymorphisms 16519T and 3010A with CVS in pediatric patients. However, it identified five pathogenic variants and eleven VUS that were associated with pediatric-onset CVS.
FRONTIERS IN PEDIATRICS
(2022)
Article
Obstetrics & Gynecology
Alex M. Kasman, Chiyuan A. Zhang, Shufeng Li, Ying Lu, Ruth B. Lathi, David K. Stevenson, Gary M. Shaw, Michael L. Eisenberg
Summary: The study showed a positive correlation between preconception paternal health and the risk of pregnancy loss, especially when fathers had metabolic syndrome and other chronic diseases. Even after adjusting for maternal factors, this association remained significant.
HUMAN REPRODUCTION
(2021)
Article
Clinical Neurology
Edyta Dziadkowiak, Malgorzata Wieczorek, Mieszko Zagrajek, Justyna Chojdak-Lukasiewicz, Ewa Gruszka, Slawomir Budrewicz, Anna Pokryszko-Dragan
Summary: This study evaluated the changes in multimodal evoked potentials (EP) and cognition in patients with clinically isolated syndrome (CIS) over a 3-year period and assessed the prognostic value of baseline findings for disease outcomes. The results showed that there were only slight changes in some EP parameters, while most parameters remained stable over time. Baseline ERP abnormalities were associated with the short-term conversion to multiple sclerosis (MS).
FRONTIERS IN NEUROLOGY
(2022)
Article
Medicine, General & Internal
Zuolin Lu, Elif Aribas, Sven Geurts, Jeanine E. Roeters van Lennep, M. Arfan Ikram, Maxime M. Bos, Natasja M. S. de Groot, Maryam Kavousi
Summary: This study found that irregular menstrual cycles, nulliparity, and multiparity were associated with a higher risk of new-onset AF among women.
Article
Obstetrics & Gynecology
Ann M. Bruno, Joshua J. Horns, Amanda A. Allshouse, Torri D. Metz, Michelle L. Debbink, Marcela C. Smid
Summary: This study aimed to evaluate the association between periviable delivery and the occurrence or worsening of mental health disorders within 12 months postpartum. A retrospective cohort study was conducted using data from the MarketScan Commercial Research Database, including liveborn singleton neonates delivered at 22 or more weeks of gestation from 2008 to 2017. The results showed a modestly increased risk of mental health morbidity in the 12 months postpartum among individuals with periviable delivery.
OBSTETRICS AND GYNECOLOGY
(2023)
Review
Clinical Neurology
Massimiliano Calabrese, Damiano Marastoni, Francesco Crescenzo, Antonio Scalfari
Summary: This review discusses the challenges in diagnosing patients with the first demyelinating attack or RIS, focusing on the updated diagnostic criteria, considering neuroinflammatory conditions in the differential diagnosis, and identifying factors that predict MS development. Accurate interpretation of demyelinating attacks, MRI results, and the importance of cerebrospinal fluid examination are emphasized for an early and precise MS diagnosis to start timely disease-modifying therapy and improve long-term outcomes.
CURRENT OPINION IN NEUROLOGY
(2021)
Article
Endocrinology & Metabolism
Qiumin Wang, Honghong Wang, Ping Li, Xiufang Li, Ze Wang, Lei Yan, Yuhua Shi
Summary: This study aims to evaluate the association between PCOS phenotypes and adverse perinatal outcomes, comparing the characteristics, ovarian response, and assisted reproductive outcomes in patients with different PCOS phenotypes after IVF/ICSI treatment. The study found that women with PCOS phenotypes A and D had a higher incidence of adverse pregnancy outcomes.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Clinical Neurology
Marco Pisa, Tommaso Croese, Gloria Dalla Costa, Simone Guerrieri, Su-Chun Huang, Annamaria Finardi, Lorena Fabbella, Francesca Sangalli, Bruno Colombo, Lucia Moiola, Vittorio Martinelli, Giancarlo Comi, Roberto Furlan, Letizia Leocani
Summary: Optical coherence tomography (OCT) is increasingly important in evaluating patients with multiple sclerosis, showing neuro-retinal changes indicative of inflammatory and disease burden. Subclinical optic nerve involvement and thinning of ganglion cell layer in eyes without acute optic neuritis are associated with greater disease burden, reflecting early disease phases.
Article
Medicine, General & Internal
Helen C. Stankiewicz Karita, Tracy Q. Dong, Christine Johnston, Kathleen M. Neuzil, Michael K. Paasche-Orlow, Patricia J. Kissinger, Anna Bershteyn, Lorna E. Thorpe, Meagan Deming, Angelica Kottkamp, Miriam Laufer, Raphael J. Landovitz, Alfred Luk, Risa Hoffman, Pavitra Roychoudhury, Craig A. Magaret, Alexander L. Greninger, Meei-Li Huang, Keith R. Jerome, Mark Wener, Connie Celum, Helen Y. Chu, Jared M. Baeten, Anna Wald, Ruanne Barnabas, Elizabeth R. Brown
Summary: This study aims to characterize the early SARS-CoV-2 viral RNA load in individuals with incident infections in association with COVID-19 symptom onset and severity.
Article
Clinical Neurology
Michael Zhong, Anneke van der Walt, Mastura Monif, Suzanne Hodgkinson, Sara Eichau, Tomas Kalincik, Jeannette Lechner-Scott, Katherine Buzzard, Olga Skibina, Vincent Van Pesch, Ernest Butler, Julie Prevost, Marc Girard, Jiwon Oh, Helmut Butzkueven, Vilija Jokubaitis
Summary: Relapse during or prior to the treatment gap, and younger age, were found to be prognostic factors in the year after switching to cladribine. Switching from NTZ was also independently associated with a higher risk of relapse.
MULTIPLE SCLEROSIS JOURNAL
(2023)
Article
Clinical Neurology
Alessio Signori, Johannes Lorscheider, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Jan Hillert, Robert Hyde, Fabio Pellegrini, Melinda Magyari, Nils Koch-Henriksen, Per Soelberg Sorensen, Tim Spelman, Anneke van Der Walt, Dana Horakova, Eva Havrdova, Marc Girard, Sara Eichau, Francois Grand'Maison, Oliver Gerlach, Murat Terzi, Serkan Ozakbas, Olga Skibina, Vincent Van Pesch, Maria Jose Sa, Julie Prevost, Raed Alroughani, Pamela A. McCombe, Riadh Gouider, Saloua Mrabet, Tamara Castillo-Trivino, Chao Zhu, Koen de Gans, Jose Luis Sanchez-Menoyo, Bassem Yamout, Samia Khoury, Maria Pia Sormani, Tomas Kalincik, Helmut Butzkueven
Summary: This study identifies different subgroups of patients with secondary progressive multiple sclerosis (SPMS) based on their longitudinal trajectories of disability. The findings suggest that SPMS patients progress at greatly different rates and the identification of distinct trajectories can guide better patient selection in future clinical trials. Additionally, the distinct trajectories may reflect heterogeneous pathological mechanisms of progression.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
(2023)
Article
Clinical Neurology
Vilija G. Jokubaitis, Maria Pia Campagna, Omar Ibrahim, Jim Stankovich, Pavlina Kleinova, Fuencisla Matesanz, Daniel Hui, Sara Eichau, Mark Slee, Jeannette Lechner-Scott, Rodney Lea, Trevor J. Kilpatrick, Tomas Kalincik, Philip L. De Jager, Ashley Beecham, Jacob L. McCauley, Bruce Taylor, Steve Vucic, Louise Laverick, Karolina Vodehnalova, Maria-Isabel Garcia-Sanchez, Antonio Alcina, Anneke van der Walt, Eva Kubala Havrdova, Guillermo Izquierdo, Nikolaos Patsopoulos, Dana Horakova, Helmut Butzkueven
Summary: Multiple sclerosis is a leading cause of adult neurological disability, and the clinical heterogeneity of the disease has made it difficult to identify genetic variants associated with outcomes. Researchers used a large international multiple sclerosis registry and machine learning to find genetic loci associated with disease severity. They found that multiple genetic loci of small effect sizes contribute to clinical outcomes.
Article
Biochemistry & Molecular Biology
Shobana Anpalakhan, Prerana Huddar, Roya Behrouzi, Alessio Signori, Judith Cave, Charles Comins, Alessio Cortellini, Alfredo Addeo, Carles Escriu, Hayley McKenzie, Gloria Barone, Lisa Murray, Gagan Bhatnagar, David J. Pinato, Christian Ottensmeier, Fabio Gomes, Giuseppe Luigi Banna
Summary: GCSF prophylaxis is recommended in patients on chemotherapy with a >20% risk of febrile neutropenia and is to be considered if there is an intermediate risk of 10-20%. GCSF has been suggested as a possible adjunct to immunotherapy due to increased peripheral neutrophil recruitment and PD-L1 expression on neutrophils with GCSF use and greater tumour volume decrease with higher tumour GCSF expression. However, its potential to increase neutrophil counts and, thus, NLR values, could subsequently confer poorer prognoses on patients with advanced NSCLC.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, Research & Experimental
Matteo Bauckneht, Cecilia Marini, Vanessa Cossu, Cristina Campi, Mattia Riondato, Silvia Bruno, Anna Maria Orengo, Francesca Vitale, Sonia Carta, Silvia Chiola, Sabrina Chiesa, Alberto Miceli, Francesca D'Amico, Giuseppe Fornarini, Carlo Terrone, Michele Piana, Silvia Morbelli, Alessio Signori, Paola Barboro, Gianmario Sambuceti
Summary: This study investigated the independent and additive prognostic value of PSMA and FDG gene expression in risk-stratification of prostate cancer (PCa). Machine learning analysis identified a predictive functional network involving glucose metabolism-related genes. Cellular experiments showed that increased proliferation and migration of PCa cells were associated with enhanced FDG uptake and decreased PSMA retention, indicating the prognostic value of FDG PET imaging.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Clinical Neurology
Giacomo Boffa, Alessio Signori, Luca Massacesi, Alice Mariottini, Elvira Sbragia, Salvatore Cottone, Maria Pia Amato, Claudio Gasperini, Lucia Moiola, Stefano Meletti, Anna Maria Repice, Vincenzo Brescia Morra, Giuseppe Salemi, Francesco Patti, Massimo Filippi, Giovanna De Luca, Giacomo Lus, Mauro Zaffaroni, Patrizia Sola, Antonella Conte, Riccardo Nistri, Umberto Aguglia, Franco Granella, Simonetta Galgani, Luisa Maria Caniatti, Alessandra Lugaresi, Silvia Romano, Pietro Iaffaldano, Eleonora Cocco, Riccardo Saccardi, Emanuele Angelucci, Maria Trojano, Giovanni Luigi Mancardi, Maria Pia Sormani, Matilde Inglese
Summary: This study compared the effects of autologous hematopoietic stem cell transplantation (AHSCT) with other anti-inflammatory disease-modifying therapies (DMTs) on long-term disability worsening in active secondary progressive multiple sclerosis (SPMS). The results showed that AHSCT was associated with a slower disability progression and a higher likelihood of disability improvement compared to standard immunotherapy.
Article
Medicine, General & Internal
Daniele Roberto Giacobbe, Emilio Di Maria, Alberto Stefano Tagliafico, Martina Bavastro, Carlo Simone Trombetta, Cristina Marelli, Gabriele Di Meco, Greta Cattardico, Sara Mora, Alessio Signori, Antonio Vena, Malgorzata Mikulska, Chiara Dentone, Bianca Bruzzone, Bianca Bignotti, Andrea Orsi, Chiara Robba, Lorenzo Ball, Iole Brunetti, Denise Battaglini, Antonio Di Biagio, Maria Pia Sormani, Paolo Pelosi, Mauro Giacomini, Giancarlo Icardi, Matteo Bassetti
Summary: This study validated the prognostic value of the FEN-COVID-19 phenotyping system in hospitalized COVID-19 patients and assessed the reproducibility of phenotypes development. The results showed that patients assigned to phenotype C had a higher mortality rate compared to phenotypes A and B.
ANNALS OF MEDICINE
(2023)
Review
Clinical Neurology
Francesco Sacca, Chiara Pane, Pablo Ezequiel Espinosa, Maria Pia Sormani, Alessio Signori
Summary: This study conducted a meta-analysis and network meta-analysis of randomized and placebo-controlled trials to evaluate the efficacy of innovative therapies in myasthenia gravis (MG). The results showed that anti-complement and FcRn treatments were effective in MG patients, while rituximab did not provide significant benefit.
EUROPEAN JOURNAL OF NEUROLOGY
(2023)
Article
Oncology
Matilde Coriano, Diana Giannarelli, Giulia Scartabellati, Ugo De Giorgi, Nicole Brighi, Giuseppe Fornarini, Chiara Tommasi, Giulia Claire Giudice, Sara Elena Rebuzzi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Matteo Santoni, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Matteo Brunelli, Alessio Signori, Giuseppe Luigi Banna, Sebastiano Buti
Summary: This study aimed to determine the impact of treatment modifications on the outcome of mRCC patients treated with cabozantinib or pazopanib. The results showed that treatment modifications based on toxicities were associated with longer PFS and OS, including dose reductions, temporary interruption, and schedule modifications. These findings were confirmed through multivariable and landmark analyses.
EXPERT REVIEW OF ANTICANCER THERAPY
(2023)
Article
Clinical Neurology
Sam Harding-Forrester, Izanne Roos, Ai-Lan Nguyen, Charles B. Malpas, Ibrahima Diouf, Nahid Moradi, Sifat Sharmin, Guillermo Izquierdo, Sara Eichau, Francesco Patti, Dana Horakova, Eva Kubala Havrdova, Alexandre Prat, Marc Girard, Pierre Duquette, Francois Grand Maison, Marco Onofrj, Alessandra Lugaresi, Pierre Grammond, Serkan Ozakbas, Maria Pia Amato, Oliver Gerlach, Patrizia Sola, Diana Ferraro, Katherine Buzzard, Olga Skibina, Jeannette Lechner-Scott, Raed Alroughani, Cavit Boz, Vincent Van Pesch, Elisabetta Cartechini, Murat Terzi, Davide Maimone, Cristina Ramo-Tello, Bassem Yamout, Samia Joseph Khoury, Daniele La Spitaleri, Maria Jose Sa, Yolanda Blanco, Franco Granella, Mark Slee, Ernest Butler, Youssef Sidhom, Riadh Gouider, Roberto Bergamaschi, Rana Karabudak, Radek Ampapa, Jose Luis Sanchez-Menoyo, Julie Prevost, Tamara Castillo-Trivino, Pamela A. McCombe, Richard Macdonell, Guy Laureys, Liesbeth Van Hijfte, Jiwon Oh, Ayse Altintas, Koen de Gans, Recai Turkoglu, Anneke van der Walt, Helmut Butzkueven, Steve Vucic, Michael Barnett, Edgardo Cristiano, Suzanne Hodgkinson, Gerardo Iuliano, Ludwig Kappos, Jens Kuhle, Vahid Shaygannejad, Aysun Soysal, Bianca Weinstock-Guttman, Bart Van Wijmeersch, Tomas Kalincik
Summary: This study compared primary and secondary progressive multiple sclerosis (PPMS, SPMS), and found that SPMS has later onset of the progressive phase and slower disability accrual, but higher baseline disability.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
(2023)
Article
Oncology
Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, Vicki E. Maltby, Mark Slee, Wei Z. Yeh, Trevor Kilpatrick, Rodney J. Scott, Helmut Butzkueven, Jeannette Lechner-Scott, Rodney A. Lea, Vilija G. Jokubaitis
Summary: This study aimed to identify DNA methylation patterns associated with parity in women with relapse-onset multiple sclerosis (wwMS). The results showed differential methylation in whole blood and immune cell types, particularly in genes related to neural plasticity. Additionally, it was found that parous women exhibited slower biological aging compared to nulligravida women.
CLINICAL EPIGENETICS
(2023)
Article
Immunology
Francesca Bridge, Helmut Butzkueven, Anneke Van der Walt, Vilija G. Jokubaitis
Summary: Menopause, which refers to the permanent cessation of ovarian function, has a significant impact on sex hormone concentrations, including estrogen, progesterone, testosterone, and anti-Mullerian hormone. These hormones are believed to have neuroinflammatory effects and are implicated in the development of multiple sclerosis (MS). Understanding the relationship between sex hormones and MS disease activity, particularly during menopause, is crucial for providing optimal care and making treatment decisions to minimize relapses, disease progression, and improve quality of life for women with MS.
AUTOIMMUNITY REVIEWS
(2023)
Article
Biochemistry & Molecular Biology
Alexandre Xavier, Vicki E. Maltby, Ewoud Ewing, Maria Pia Campagna, Sean M. Burnard, Jesper N. Tegner, Mark Slee, Helmut Butzkueven, Ingrid Kockum, Lara Kular, Vilija G. Jokubaitis, Trevor Kilpatrick, Lars Alfredsson, Maja Jagodic, Anne-Louise Ponsonby, Bruce V. Taylor, Rodney J. Scott, Rodney A. Lea, Jeannette Lechner-Scott
Summary: This study reveals that DNA methylation differences in multiple sclerosis (MS) occur independently of known genetic risk loci. It shows that these differences more effectively differentiate the disease compared to known genetic risk loci. The study also indicates that the methylation differences in MS predominantly occur in B cells and monocytes, involving cell-specific biological pathways.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Clinical Neurology
Vicki Maltby, Alexandre Xavier, Ewoud Ewing, Maria-Pia Campagna, Sandeep Sampangi, Rodney J. Scott, Helmut Butzkueven, Vilija Jokubaitis, Lara Kular, Steffan Bos, Mark Slee, Ingrid A. van der Mei, Bruce V. Taylor, Anne-Louise Ponsonby, Maja Jagodic, Rodney Lea, Jeannette Lechner-Scott
Summary: This study used existing DNAm data from multiple independent studies to investigate cell-specific epigenetic age acceleration (EAA) in people with multiple sclerosis (MS). The results showed that MS patients had significantly increased EAA compared to controls, and this effect was specifically associated with B cells. This study provides evidence for the role of premature B cell immune senescence in MS.
Review
Clinical Neurology
Kristen M. Krysko, Ruth Dobson, Raed Alroughani, Maria Pia Amato, Riley Bove, Andrea Ciplea, Yara Fragoso, Maria Houtchens, Vilija G. Jokubaitis, Melinda Magyari, Azza Abdelnasser, Vasantha Padma, Sandra Thiel, Mar Tintore, Sandra Vukusic, Kerstin Hellwig
Summary: Multiple sclerosis (MS) is frequently diagnosed in women intending to have children. The effects of fetal exposure to novel disease-modifying therapies (DMTs) used in the treatment of MS are not well understood. Discontinuation of certain DMTs during pregnancy may increase the risk of relapse and disability. More research is needed to understand the outcomes of neonates exposed to DMTs and guide individualized treatment decisions. Periodic updates will be necessary to provide the latest guidance on achieving MS stability during pregnancy and postpartum while ensuring the safety of the mother and newborn.